Anakinra for children with severe heart muscle swelling
Part of Heart & circulation clinical trials.
This study tests a medicine called anakinra that may reduce heart swelling in children with a severe heart condition called acute myocarditis. It might help their heart recover faster while they are in the intensive care unit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Children aged 3 months to under 18 years
- Currently hospitalized in the intensive care unit due to acute myocarditis (heart muscle inflammation)
- Have a weakened heart pumping ability (ejection fraction below 50%) and a high troponin level
- Weigh at least 5 kilograms
- No previous heart muscle disease or heart surgery
- Have consent from a parent or legal guardian
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two treatments—anakinra and IVIG—for children with Kawasaki disease who still have fever after their first standard IVIG treatment. It aims to find which option works better and is safer for “IVIG non-responders” who may be at risk for heart complications.
This trial tests if taking anakinra (a targeted medicine) only when you have a painful FMF attack can help, instead of taking it every day. It is for people with Familial Mediterranean Fever (FMF) whose attacks continue despite taking colchicine, and who do not want daily injections.
This trial tests different doses and ways of giving a medicine called anakinra to preterm babies. It aims to find the safest and most effective dose to help reduce inflammation.
This study tests whether anakinra, a medicine that calms inflammation, is just as good as the standard treatment for Kawasaki disease in children. The goal is to reduce fever and prevent heart problems.
This study tests whether a drug called anakinra, given as a shot, can help treat moderate asthma attacks right when they happen, reducing the need for other rescue treatments. It may help people whose asthma is not well controlled and who have needed steroids in the past year.
This study tests whether a medicine called anakinra can “turn down” harmful inflammation in children with severe illness from sepsis. It aims to improve organ function when multiple organs are starting to fail.
Hear when a new PEDIATRIC ACUTE MYOCARDITIS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.